Animal noses inspire new mask, air filter designs

A new 3D-printable mask design, inspired by animal noses, promises easy breathing for users while maintaining similar levels of protection against pathogens found in N95 and surgical masks.

Discovery may help reduce side effects of MS drugs

Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have discovered how a drug for multiple sclerosis interacts with its targets, a finding that may pave the way for better treatments.

Anesthesia costs rise with corporate outsourcing

Anesthesiology prices jump significantly after medical facilities contract with corporate physician management companies – especially those backed by private equity firms – and threaten to hike patient costs, according to new research.

Virtual reality farm tour expands access to urban agriculture

Cornell researchers have created the most advanced virtual reality urban farm tour ever made, an online learning experience that promises to transport urban and rural farmers to New York City’s Red Hook Farms without ever leaving home.

Cornell’s UN climate author warns of ‘rapidly closing window’

In a global cautionary tale, the UN’s IPCC has a new climate change report written by Cornell’s Rachel Bezner Kerr and 270 others, to pull our planet from dire environmental ruin.

Scientists identify key regulator of malaria parasite spread

A finding from Weill Cornell Medicine researchers sheds new light on the transmission of malaria, one of the biggest global public health challenges.

Electrosynthesis energizes sustainable drug development

A Cornell-led collaboration used electrochemistry to stitch together simple carbon molecules and form complex compounds, eliminating the need for precious metals or other catalysts to promote the chemical reaction.

Students’ tool forecasts manganese in Ithaca water supply

To help the Ithaca Water Treatment Plant, engineering students have created a way to help predict concentrations of manganese in the city’s reservoir.

Patient possibly cured of HIV infection by special stem-cell transplant

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.